A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • UCLA, Santa Monica, California, United States

  • Stanford University, Stanford, California, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States